Guggenheim Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Guggenheim
Rating: 2.7
Author: MarketBeat

→ Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Guggenheim. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Guggenheim.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
ANIP ANI Pharmaceuticals	$66.14 +0.8%	4/23/2024	Reiterated by	Guggenheim	-	Buy -> Buy	$77.00	Low	View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 4/23/2024
IMCR Immunocore	$57.31 +2.7%	4/23/2024	Reiterated by	Guggenheim	-	Buy -> Buy	$92.00	Low	View details for Guggenheim rating of Immunocore (NASDAQ:IMCR) on 4/23/2024
INFA Informatica	$31.39 -0.3%	4/23/2024	Reiterated by	Guggenheim	-	Buy -> Buy	$37.00	Low	View details for Guggenheim rating of Informatica (NYSE:INFA) on 4/23/2024
TSLA Tesla	$144.68 +1.9%	4/23/2024	Reiterated by	Guggenheim	-	Sell -> Sell	$122.00	Low	View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 4/23/2024
NXT Nextracker	$44.42 +1.0%	4/23/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$73.00 -> $60.00	Low	View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 4/23/2024
SBUX Starbucks	$87.87 -0.4%	4/19/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$100.00 -> $91.00	Low	View details for Guggenheim rating of Starbucks (NASDAQ:SBUX) on 4/19/2024
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
VRTX Vertex Pharmaceuticals	$404.91 +1.2%	4/18/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$445.00 -> $450.00	Low	View details for Guggenheim rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/18/2024
AN AutoNation	$158.36 +2.5%	4/17/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$165.00 -> $169.00	N/A	View details for Guggenheim rating of AutoNation (NYSE:AN) on 4/17/2024
APTV Aptiv	$70.25 +0.2%	4/17/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$103.00 -> $92.00	N/A	View details for Guggenheim rating of Aptiv (NYSE:APTV) on 4/17/2024
GNTX Gentex	$34.66 +1.2%	4/17/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$40.00 -> $41.00	N/A	View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 4/17/2024
LAD Lithia Motors	$264.58 +1.4%	4/17/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$320.00 -> $297.00	N/A	View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 4/17/2024
VC Visteon	$109.81 +1.7%	4/17/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$136.00 -> $126.00	N/A	View details for Guggenheim rating of Visteon (NASDAQ:VC) on 4/17/2024
GPI Group 1 Automotive	$279.54 +4.1%	4/17/2024	Upgraded by	Guggenheim	-	Neutral -> Buy	$305.00	Low	View details for Guggenheim rating of Group 1 Automotive (NYSE:GPI) on 4/17/2024
NFLX Netflix	$577.75 +4.2%	4/16/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$600.00 -> $700.00	Low	View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 4/16/2024
NOW ServiceNow	$740.95 +2.6%	4/15/2024	Reiterated by	Guggenheim	-	Buy -> Neutral		Low	View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 4/15/2024
IMNM Immunome	$14.66 -4.1%	4/15/2024	Initiated by	Guggenheim	-	Buy	$35.00	Low	View details for Guggenheim rating of Immunome (NASDAQ:IMNM) on 4/15/2024
ENGN enGene	$15.26 +3.1%	4/15/2024	Initiated by	Guggenheim	-	Buy	$34.00	Low	View details for Guggenheim rating of enGene (NASDAQ:ENGN) on 4/15/2024
ALPN Alpine Immune Sciences	$64.55 0.0%	4/9/2024	Initiated by	Guggenheim	-	Buy	$55.00	Low	View details for Guggenheim rating of Alpine Immune Sciences (NASDAQ:ALPN) on 4/9/2024
VERA Vera Therapeutics	$39.52 +1.0%	4/5/2024	Reiterated by	Guggenheim	-	Buy -> Buy	$56.00	Low	View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 4/5/2024
WMG Warner Music Group	$32.14 -2.8%	4/5/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$46.00 -> $45.00	Low	View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 4/5/2024
RCM R1 RCM	$11.75 -1.3%	4/5/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$17.00 -> $15.00	Low	View details for Guggenheim rating of R1 RCM (NASDAQ:RCM) on 4/5/2024
ARRY Array Technologies	$11.94 +2.1%	4/5/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$20.00 -> $22.00	N/A	View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 4/5/2024
BROS Dutch Bros	$28.80	4/5/2024	Reiterated by	Guggenheim	-	Neutral -> Neutral	$30.00	Low	View details for Guggenheim rating of Dutch Bros (NYSE:BROS) on 4/5/2024
ADCT ADC Therapeutics	$4.97 +6.2%	4/5/2024	Reiterated by	Guggenheim	-	Buy		Low	View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 4/5/2024
CVAC CureVac	$2.60 +2.8%	4/5/2024	Reiterated by	Guggenheim	-	Neutral		Low	View details for Guggenheim rating of CureVac (NASDAQ:CVAC) on 4/5/2024
GH Guardant Health	$17.34 -1.4%	4/5/2024	Reiterated by	Guggenheim	-	Neutral		Low	View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 4/5/2024
HD Home Depot	$339.00 +0.9%	4/5/2024	Reiterated by	Guggenheim	-	Buy -> Buy	$390.00	Low	View details for Guggenheim rating of Home Depot (NYSE:HD) on 4/5/2024
IVVD Invivyd	$2.27 +3.7%	4/5/2024	Upgraded by	Guggenheim	-	Neutral -> Buy	$9.00	Low	View details for Guggenheim rating of Invivyd (NASDAQ:IVVD) on 4/5/2024
PRKS United Parks & Resorts	$52.89 +2.0%	4/4/2024	Initiated by	Guggenheim	-	Buy	$73.00	Low	View details for Guggenheim rating of United Parks & Resorts (NYSE:PRKS) on 4/4/2024
DIS Walt Disney	$113.72 +1.5%	4/3/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$125.00 -> $140.00	Low	View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 4/3/2024
EDR Endeavor Group	$26.35 -0.3%	4/3/2024	Reiterated by	Guggenheim	-	Buy -> Neutral	$36.00 -> $27.50	Low	View details for Guggenheim rating of Endeavor Group (NYSE:EDR) on 4/3/2024
PVH PVH	$112.64 +2.8%	4/2/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$120.00 -> $140.00	Low	View details for Guggenheim rating of PVH (NYSE:PVH) on 4/2/2024
ADCT ADC Therapeutics	$4.97 +6.2%	3/28/2024	Initiated by	Guggenheim	-	Buy	$11.00	Low	View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 3/28/2024
VERA Vera Therapeutics	$39.52 +1.0%	3/27/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$27.00 -> $56.00	Low	View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 3/27/2024
TVTX Travere Therapeutics	$5.74 -1.9%	3/27/2024	Reiterated by	Guggenheim	-	Buy -> Neutral		Low	View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 3/27/2024
VYGR Voyager Therapeutics	$7.65 +1.1%	3/26/2024	Initiated by	Guggenheim	-	Buy	$22.00	Low	View details for Guggenheim rating of Voyager Therapeutics (NASDAQ:VYGR) on 3/26/2024
VALN Valneva	$7.74 -2.3%	3/22/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$18.00 -> $17.00	Low	View details for Guggenheim rating of Valneva (NASDAQ:VALN) on 3/22/2024
ABBV AbbVie	$169.54 +1.0%	3/22/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$188.00 -> $190.00	Low	View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 3/22/2024
LULU Lululemon Athletica	$364.68 +0.8%	3/22/2024	Target Lowered by	Guggenheim	-	Buy	$550.00 -> $525.00	Low	View details for Guggenheim rating of Lululemon Athletica (NASDAQ:LULU) on 3/22/2024
TSQ Townsquare Media	$12.58 +2.0%	3/20/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$12.00 -> $12.50	Low	View details for Guggenheim rating of Townsquare Media (NYSE:TSQ) on 3/20/2024
Exposed: 10 CENT Crypto to Explode April 20th? (Ad) Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024
TIXT TELUS International (Cda)	$8.04 +0.4%	3/19/2024	Initiated by	Guggenheim	-	Neutral	$9.00	Low	View details for Guggenheim rating of TELUS International (Cda) (NYSE:TIXT) on 3/19/2024
TASK TaskUs	$11.15 +1.1%	3/19/2024	Initiated by	Guggenheim	-	Neutral	$13.00	Low	View details for Guggenheim rating of TaskUs (NASDAQ:TASK) on 3/19/2024
DXC DXC Technology	$21.16 +3.6%	3/19/2024	Initiated by	Guggenheim	-	Neutral	$22.00	Low	View details for Guggenheim rating of DXC Technology (NYSE:DXC) on 3/19/2024
TTEC TTEC	$8.10 -0.7%	3/19/2024	Initiated by	Guggenheim	-	Sell	$8.00	Low	View details for Guggenheim rating of TTEC (NASDAQ:TTEC) on 3/19/2024
PRFT Perficient	$45.48 +0.8%	3/19/2024	Initiated by	Guggenheim	-	Neutral	$65.00	Low	View details for Guggenheim rating of Perficient (NASDAQ:PRFT) on 3/19/2024
GLOB Globant	$180.90 +0.4%	3/19/2024	Initiated by	Guggenheim	-	Buy	$250.00	Low	View details for Guggenheim rating of Globant (NYSE:GLOB) on 3/19/2024
DAVA Endava	$30.30 +2.2%	3/19/2024	Initiated by	Guggenheim	-	Buy	$60.00	Low	View details for Guggenheim rating of Endava (NYSE:DAVA) on 3/19/2024
DRI Darden Restaurants	$155.91 +0.9%	3/19/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$180.00 -> $185.00	Low	View details for Guggenheim rating of Darden Restaurants (NYSE:DRI) on 3/19/2024
GNTX Gentex	$34.66 +1.2%	3/19/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$38.00 -> $40.00	Low	View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 3/19/2024
KR Kroger	$55.62 -2.3%	3/19/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$60.00 -> $61.00	Low	View details for Guggenheim rating of Kroger (NYSE:KR) on 3/19/2024
ACN Accenture	$316.80 -0.2%	3/19/2024	Initiated by	Guggenheim	-	Buy	$425.00	Low	View details for Guggenheim rating of Accenture (NYSE:ACN) on 3/19/2024
INFY Infosys	$17.18 -0.7%	3/19/2024	Initiated by	Guggenheim	-	Neutral	$20.00	Low	View details for Guggenheim rating of Infosys (NYSE:INFY) on 3/19/2024
CTSH Cognizant Technology Solutions	$67.77 -0.6%	3/19/2024	Initiated by	Guggenheim	-	Neutral	$80.00	Low	View details for Guggenheim rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 3/19/2024
EPAM EPAM Systems	$247.86 +0.4%	3/19/2024	Initiated by	Guggenheim	-	Buy	$350.00	Low	View details for Guggenheim rating of EPAM Systems (NYSE:EPAM) on 3/19/2024
IMRX Immuneering	$1.63 -5.2%	3/14/2024	Reiterated by	Guggenheim	-	Buy -> Neutral		Low	View details for Guggenheim rating of Immuneering (NASDAQ:IMRX) on 3/14/2024
WW WW International	$1.72 +5.5%	3/18/2024	Reiterated by	Guggenheim	-	Buy -> Buy	$12.00	Low	View details for Guggenheim rating of WW International (NASDAQ:WW) on 3/18/2024
SNOW Snowflake	$151.17 +2.7%	3/15/2024	Upgraded by	Guggenheim	-	Sell -> Neutral		Low	View details for Guggenheim rating of Snowflake (NYSE:SNOW) on 3/15/2024
SIRI Sirius XM	$3.16 +1.0%	3/14/2024	Initiated by	Guggenheim	-	Neutral	$4.00	Low	View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 3/14/2024
SPRB Spruce Biosciences	$0.70 +1.4%	3/14/2024	Downgraded by	Guggenheim	-	Buy -> Neutral		Low	View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 3/14/2024
FL Foot Locker	$22.25 +3.2%	3/7/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$35.00 -> $30.00	Low	View details for Guggenheim rating of Foot Locker (NYSE:FL) on 3/7/2024
EOSE Eos Energy Enterprises	$0.77	3/7/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$10.00 -> $4.00	Low	View details for Guggenheim rating of Eos Energy Enterprises (NASDAQ:EOSE) on 3/7/2024
YUM Yum! Brands	$140.10 +0.7%	3/7/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$145.00 -> $155.00	Low	View details for Guggenheim rating of Yum! Brands (NYSE:YUM) on 3/7/2024
BASE Couchbase	$24.09 +4.5%	3/6/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$27.00 -> $32.00	Low	View details for Guggenheim rating of Couchbase (NASDAQ:BASE) on 3/6/2024
CRWD CrowdStrike	$299.65 +3.6%	3/6/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$358.00 -> $424.00	N/A	View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024
ROST Ross Stores	$133.09 -0.5%	3/6/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$140.00 -> $165.00	Low	View details for Guggenheim rating of Ross Stores (NASDAQ:ROST) on 3/6/2024
TGT Target	$166.51 -0.4%	3/6/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$160.00 -> $190.00	Low	View details for Guggenheim rating of Target (NYSE:TGT) on 3/6/2024
ANIP ANI Pharmaceuticals	$66.14 +0.8%	3/5/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$70.00 -> $77.00	Low	View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 3/5/2024
PRME Prime Medicine	$4.80 +0.4%	3/5/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$24.00 -> $20.00	Low	View details for Guggenheim rating of Prime Medicine (NYSE:PRME) on 3/5/2024
APGE Apogee Therapeutics	$49.77 +2.3%	3/5/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$44.00 -> $91.00	Low	View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 3/5/2024
DLTR Dollar Tree	$122.56 +0.7%	3/5/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$155.00 -> $170.00	Low	View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 3/5/2024
IHRT iHeartMedia	$2.12 +9.3%	3/4/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$6.00 -> $5.00	Low	View details for Guggenheim rating of iHeartMedia (NASDAQ:IHRT) on 3/4/2024
MDB MongoDB	$366.31 +7.7%	3/4/2024	Target Raised by	Guggenheim	-	Sell -> Sell	$250.00 -> $272.00	Low	View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 3/4/2024
D Dominion Energy	$50.67 +0.1%	3/4/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$57.00 -> $52.00	Low	View details for Guggenheim rating of Dominion Energy (NYSE:D) on 3/4/2024
GSK GSK	$41.24 +1.6%	3/4/2024	Upgraded by	Guggenheim	-	Neutral -> Buy		Low	View details for Guggenheim rating of GSK (NYSE:GSK) on 3/4/2024
AMRC Ameresco	$20.87 +9.3%	2/29/2024	Reiterated by	Guggenheim	-	Buy -> Neutral		Low	View details for Guggenheim rating of Ameresco (NYSE:AMRC) on 2/29/2024
MRSN Mersana Therapeutics	$3.21 +1.9%	2/29/2024	Upgraded by	Guggenheim	-	Neutral -> Buy	$7.00	Low	View details for Guggenheim rating of Mersana Therapeutics (NASDAQ:MRSN) on 2/29/2024
NUVL Nuvalent	$67.60 +4.8%	2/28/2024	Initiated by	Guggenheim	-	Buy	$99.00	Low	View details for Guggenheim rating of Nuvalent (NASDAQ:NUVL) on 2/28/2024
INSM Insmed	$25.27 +4.8%	2/27/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$52.00 -> $54.00	Low	View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 2/27/2024
KRYS Krystal Biotech	$162.04 +3.0%	2/27/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$130.00 -> $175.00	Low	View details for Guggenheim rating of Krystal Biotech (NASDAQ:KRYS) on 2/27/2024
WDAY Workday	$256.82 +1.3%	2/27/2024	Reiterated by	Guggenheim	-	Sell -> Sell	$190.00	Low	View details for Guggenheim rating of Workday (NASDAQ:WDAY) on 2/27/2024
BGNE BeiGene	$138.99 +6.1%	2/27/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$350.00 -> $345.00	Low	View details for Guggenheim rating of BeiGene (NASDAQ:BGNE) on 2/27/2024
CLDX Celldex Therapeutics	$37.77 -2.8%	2/27/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$72.00 -> $90.00	Low	View details for Guggenheim rating of Celldex Therapeutics (NASDAQ:CLDX) on 2/27/2024
HIMS Hims & Hers Health	$12.33 +3.8%	2/27/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$15.00 -> $17.00	Low	View details for Guggenheim rating of Hims & Hers Health (NYSE:HIMS) on 2/27/2024
FND Floor & Decor	$110.00 +1.4%	2/27/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$115.00 -> $130.00	Low	View details for Guggenheim rating of Floor & Decor (NYSE:FND) on 2/27/2024
PFE Pfizer	$26.32 +0.2%	2/23/2024	Initiated by	Guggenheim	-	Buy	$36.00	Low	View details for Guggenheim rating of Pfizer (NYSE:PFE) on 2/23/2024
AXSM Axsome Therapeutics	$73.08 +2.8%	2/21/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$110.00 -> $125.00	Low	View details for Guggenheim rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/21/2024
CNP CenterPoint Energy	$28.73 -0.2%	2/21/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$33.00 -> $32.00	Low	View details for Guggenheim rating of CenterPoint Energy (NYSE:CNP) on 2/21/2024
CRWD CrowdStrike	$299.65 +3.6%	2/21/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$274.00 -> $358.00	Low	View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 2/21/2024
HD Home Depot	$339.00 +0.9%	2/21/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$370.00 -> $390.00	Low	View details for Guggenheim rating of Home Depot (NYSE:HD) on 2/21/2024
S SentinelOne	$21.19 +3.5%	2/21/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$26.00 -> $32.00	Low	View details for Guggenheim rating of SentinelOne (NYSE:S) on 2/21/2024
Exposed: 10 CENT Crypto to Explode April 20th? (Ad) Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024
SPRB Spruce Biosciences	$0.70 +1.4%	2/21/2024	Initiated by	Guggenheim	-	Buy	$10.00	Low	View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 2/21/2024
BTSG BrightSpring Health Services	$10.70 +0.8%	2/20/2024	Initiated by	Guggenheim	-	Buy	$15.00	Low	View details for Guggenheim rating of BrightSpring Health Services (NASDAQ:BTSG) on 2/20/2024
SPWR SunPower	$1.96 -8.4%	2/16/2024	Downgraded by	Guggenheim	-	Neutral -> Sell		Low	View details for Guggenheim rating of SunPower (NASDAQ:SPWR) on 2/16/2024
CRL Charles River Laboratories International	$239.98 +3.2%	2/15/2024	Downgraded by	Guggenheim	-	Buy -> Neutral		Low	View details for Guggenheim rating of Charles River Laboratories International (NYSE:CRL) on 2/15/2024
IQV IQVIA	$238.74 +3.2%	2/15/2024	Downgraded by	Guggenheim	-	Buy -> Neutral		Low	View details for Guggenheim rating of IQVIA (NYSE:IQV) on 2/15/2024
GNRC Generac	$136.10 +1.5%	2/15/2024	Downgraded by	Guggenheim	-	Buy -> Neutral		Low	View details for Guggenheim rating of Generac (NYSE:GNRC) on 2/15/2024
QSR Restaurant Brands International	$74.36 +1.4%	2/14/2024	Target Raised by	Guggenheim	-	Neutral	$70.00 -> $74.00	Low	View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 2/14/2024
NXT Nextracker	$44.42 +1.0%	2/8/2024	Initiated by	Guggenheim	-	Buy	$73.00	Low	View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 2/8/2024
SWTX SpringWorks Therapeutics	$44.00 +2.6%	2/5/2024	Initiated by	Guggenheim	-	Buy	$75.00	Low	View details for Guggenheim rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 2/5/2024
SN SharkNinja	62.55 +1.1%	2/5/2024	Initiated by	Guggenheim	-	Buy	60.00	Low	View details for Guggenheim rating of SharkNinja (NYSE:SN) on 2/5/2024
APTV Aptiv	$70.25 +0.2%	2/2/2024	Target Lowered by	Guggenheim	-	Buy -> Buy	$120.00 -> $103.00	Low	View details for Guggenheim rating of Aptiv (NYSE:APTV) on 2/2/2024
TSCO Tractor Supply	$255.96 +1.0%	2/2/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$210.00 -> $255.00	Low	View details for Guggenheim rating of Tractor Supply (NASDAQ:TSCO) on 2/2/2024
META Meta Platforms	$496.10 +3.0%	2/2/2024	Target Raised by	Guggenheim	-	Buy	$380.00 -> $520.00	Low	View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 2/2/2024
CMS CMS Energy	$59.90 -0.2%	2/2/2024	Upgraded by	Guggenheim	-	Neutral -> Buy	$60.00 -> $64.00	Low	View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 2/2/2024
HCAT Health Catalyst	$5.60 +0.7%	1/26/2024	Upgraded by	Guggenheim	-	Neutral -> Buy	$14.00	Low	View details for Guggenheim rating of Health Catalyst (NASDAQ:HCAT) on 1/26/2024
OTLK Outlook Therapeutics	$8.20 +1.4%	1/25/2024	Upgraded by	Guggenheim	-	Neutral -> Buy	$40.00	Low	View details for Guggenheim rating of Outlook Therapeutics (NASDAQ:OTLK) on 1/25/2024
NFLX Netflix	$577.75 +4.2%	1/24/2024	Target Raised by	Guggenheim	-	Buy	$500.00 -> $600.00	Low	View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 1/24/2024
NEE NextEra Energy	$66.18 +1.3%	1/22/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$70.00 -> $80.00	Low	View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 1/22/2024
PEG Public Service Enterprise Group	$66.49 -0.3%	1/22/2024	Downgraded by	Guggenheim	-	Buy -> Neutral	$61.00	Low	View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 1/22/2024
IDA IDACORP	$94.13 -0.2%	1/22/2024	Downgraded by	Guggenheim	-	Buy -> Neutral	$93.00	Low	View details for Guggenheim rating of IDACORP (NYSE:IDA) on 1/22/2024
PNW Pinnacle West Capital	$74.50 -0.3%	1/22/2024	Upgraded by	Guggenheim	-	Neutral -> Buy	$78.00	Low	View details for Guggenheim rating of Pinnacle West Capital (NYSE:PNW) on 1/22/2024
NWE NorthWestern Energy Group	$50.45 +0.1%	1/22/2024	Upgraded by	Guggenheim	-	Sell -> Neutral	$47.00	Low	View details for Guggenheim rating of NorthWestern Energy Group (NYSE:NWE) on 1/22/2024
EVRG Evergy	$52.25 0.0%	1/22/2024	Downgraded by	Guggenheim	-	Buy -> Neutral	$52.00	Low	View details for Guggenheim rating of Evergy (NYSE:EVRG) on 1/22/2024
DTE DTE Energy	$110.11 0.0%	1/22/2024	Downgraded by	Guggenheim	-	Buy -> Neutral	$111.00	Low	View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 1/22/2024
AEP American Electric Power	$85.56 +0.8%	1/22/2024	Downgraded by	Guggenheim	-	Buy -> Neutral	$81.00	Low	View details for Guggenheim rating of American Electric Power (NASDAQ:AEP) on 1/22/2024
ES Eversource Energy	$60.34 +0.1%	1/22/2024	Upgraded by	Guggenheim	-	Neutral -> Buy	$60.00 -> $72.00	Low	View details for Guggenheim rating of Eversource Energy (NYSE:ES) on 1/22/2024
EIX Edison International	$70.81 +0.2%	1/22/2024	Upgraded by	Guggenheim	-	Neutral -> Buy	$66.00 -> $84.00	Low	View details for Guggenheim rating of Edison International (NYSE:EIX) on 1/22/2024
AVA Avista	$35.56 +0.6%	1/22/2024	Upgraded by	Guggenheim	-	Sell -> Neutral	$34.00	Low	View details for Guggenheim rating of Avista (NYSE:AVA) on 1/22/2024
ALE ALLETE	$59.80 -0.3%	1/22/2024	Upgraded by	Guggenheim	-	Sell -> Neutral	$58.00	Low	View details for Guggenheim rating of ALLETE (NYSE:ALE) on 1/22/2024
NAMS NewAmsterdam Pharma	$21.45 +6.0%	1/18/2024	Initiated by	Guggenheim	-	Buy	$30.00	Low	View details for Guggenheim rating of NewAmsterdam Pharma (NASDAQ:NAMS) on 1/18/2024
ALLO Allogene Therapeutics	$3.37 -0.9%	1/5/2024	Downgraded by	Guggenheim	-	Buy -> Neutral		Low	View details for Guggenheim rating of Allogene Therapeutics (NASDAQ:ALLO) on 1/5/2024
APGE Apogee Therapeutics	$49.77 +2.3%	1/3/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$29.00 -> $44.00	Low	View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 1/3/2024
LBPH Longboard Pharmaceuticals	$20.27 +8.6%	1/2/2024	Target Raised by	Guggenheim	-	Buy -> Buy	$16.00 -> $32.00	Low	View details for Guggenheim rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 1/2/2024
KRTX Karuna Therapeutics	$329.83	12/22/2023	Reiterated by	Guggenheim	-	Buy -> Neutral		Low	View details for Guggenheim rating of Karuna Therapeutics (NASDAQ:KRTX) on 12/22/2023
WW WW International	$1.72 +5.5%	12/20/2023	Initiated by	Guggenheim	-	Buy	$14.00	Low	View details for Guggenheim rating of WW International (NASDAQ:WW) on 12/20/2023
SNAP Snap	$11.40 +2.3%	12/18/2023	Upgraded by	Guggenheim	-	Neutral -> Buy	$9.00 -> $23.00	Low	View details for Guggenheim rating of Snap (NYSE:SNAP) on 12/18/2023
ETSY Etsy	$68.35 +2.9%	12/15/2023	Target Raised by	Guggenheim	-	Buy -> Buy	$75.00 -> $95.00	Low	View details for Guggenheim rating of Etsy (NASDAQ:ETSY) on 12/15/2023
TSLA Tesla	$144.68 +1.9%	12/15/2023	Target Raised by	Guggenheim	-	Sell -> Sell	$125.00 -> $132.00	Low	View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 12/15/2023
EXC Exelon	$37.56 -0.3%	12/15/2023	Downgraded by	Guggenheim	-	Buy -> Neutral	$44.00 -> $40.00	Low	View details for Guggenheim rating of Exelon (NASDAQ:EXC) on 12/15/2023
PACB Pacific Biosciences of California	$1.47 -5.8%	12/14/2023	Initiated by	Guggenheim	-	Neutral		Low	View details for Guggenheim rating of Pacific Biosciences of California (NASDAQ:PACB) on 12/14/2023
NTRA Natera	$91.04 +2.7%	12/14/2023	Initiated by	Guggenheim	-	Buy	$70.00	Low	View details for Guggenheim rating of Natera (NASDAQ:NTRA) on 12/14/2023
TXG 10x Genomics	$27.58 -0.8%	12/14/2023	Initiated by	Guggenheim	-	Buy	$60.00	Low	View details for Guggenheim rating of 10x Genomics (NASDAQ:TXG) on 12/14/2023
MYGN Myriad Genetics	$18.60 +0.6%	12/14/2023	Initiated by	Guggenheim	-	Buy	$23.00	Low	View details for Guggenheim rating of Myriad Genetics (NASDAQ:MYGN) on 12/14/2023
ILMN Illumina	$124.46 +3.5%	12/14/2023	Initiated by	Guggenheim	-	Buy	$155.00	Low	View details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 12/14/2023
GH Guardant Health	$17.34 -1.4%	12/14/2023	Initiated by	Guggenheim	-	Neutral		Low	View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 12/14/2023
EXAS Exact Sciences	$63.53 +1.8%	12/14/2023	Initiated by	Guggenheim	-	Buy	$90.00	Low	View details for Guggenheim rating of Exact Sciences (NASDAQ:EXAS) on 12/14/2023
CSTL Castle Biosciences	$20.06 +2.3%	12/14/2023	Initiated by	Guggenheim	-	Buy	$25.00	Low	View details for Guggenheim rating of Castle Biosciences (NASDAQ:CSTL) on 12/14/2023
AKYA Akoya Biosciences	$3.81 -2.3%	12/14/2023	Initiated by	Guggenheim	-	Neutral		Low	View details for Guggenheim rating of Akoya Biosciences (NASDAQ:AKYA) on 12/14/2023
SYRE Spyre Therapeutics	$34.25 +2.9%	12/11/2023	Initiated by	Guggenheim	-	Buy	$44.00	Low	View details for Guggenheim rating of Spyre Therapeutics (NASDAQ:SYRE) on 12/11/2023
PSTG Pure Storage	$51.80 +2.6%	12/7/2023	Initiated by	Guggenheim	-	Buy	$48.00	Low	View details for Guggenheim rating of Pure Storage (NYSE:PSTG) on 12/7/2023
Exposed: 10 CENT Crypto to Explode April 20th? (Ad) Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024
NEE NextEra Energy	$66.18 +1.3%	12/6/2023	Target Raised by	Guggenheim	-	Buy -> Buy	$65.00 -> $70.00	Low	View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 12/6/2023
NEP NextEra Energy Partners	$28.71 +4.6%	12/6/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$42.00 -> $37.00	Low	View details for Guggenheim rating of NextEra Energy Partners (NYSE:NEP) on 12/6/2023
SPHR Sphere Entertainment	$42.20 +1.8%	12/6/2023	Upgraded by	Guggenheim	-	Neutral -> Buy	$38.00 -> $40.00	Low	View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 12/6/2023
INCY Incyte	$51.65 -0.5%	12/4/2023	Upgraded by	Guggenheim	-	Neutral -> Buy	$86.00	Low	View details for Guggenheim rating of Incyte (NASDAQ:INCY) on 12/4/2023
SLNO Soleno Therapeutics	$40.14 +6.9%	11/21/2023	Reiterated by	Guggenheim	-	Buy	$40.00	Low	View details for Guggenheim rating of Soleno Therapeutics (NASDAQ:SLNO) on 11/21/2023
ARVN Arvinas	$34.00 -2.6%	11/20/2023	Upgraded by	Guggenheim	-	Neutral -> Buy	$40.00	Low	View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 11/20/2023
BWA BorgWarner	$33.34 +0.8%	11/16/2023	Upgraded by	Guggenheim	-	Neutral -> Buy	$41.00	Low	View details for Guggenheim rating of BorgWarner (NYSE:BWA) on 11/16/2023
DKNG DraftKings	$41.21 +1.6%	11/15/2023	Target Raised by	Guggenheim	-	Buy -> Buy	$39.00 -> $45.00	Low	View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 11/15/2023
HD Home Depot	$339.00 +0.9%	11/15/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$360.00 -> $340.00	Low	View details for Guggenheim rating of Home Depot (NYSE:HD) on 11/15/2023
HLVX HilleVax	$12.81 -1.3%	11/15/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$38.00 -> $34.00	Low	View details for Guggenheim rating of HilleVax (NASDAQ:HLVX) on 11/15/2023
MLTX MoonLake Immunotherapeutics	$43.25 +5.4%	11/15/2023	Target Raised by	Guggenheim	-	Buy -> Buy	$70.00 -> $77.00	Low	View details for Guggenheim rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/15/2023
ROIV Roivant Sciences	$10.94 +3.2%	11/15/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$17.00 -> $16.00	Low	View details for Guggenheim rating of Roivant Sciences (NASDAQ:ROIV) on 11/15/2023
XPOF Xponential Fitness	$12.59 -0.9%	11/15/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$30.00 -> $25.00	Low	View details for Guggenheim rating of Xponential Fitness (NYSE:XPOF) on 11/15/2023
ARRY Array Technologies	$11.94 +2.1%	11/8/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$36.00 -> $30.00	N/A	View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 11/8/2023
IDYA IDEAYA Biosciences	$39.02 +3.8%	11/8/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$48.00 -> $44.00	Low	View details for Guggenheim rating of IDEAYA Biosciences (NASDAQ:IDYA) on 11/8/2023
TKO TKO Group	$95.67 +0.2%	11/8/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$126.00 -> $120.00	Low	View details for Guggenheim rating of TKO Group (NYSE:TKO) on 11/8/2023
XNCR Xencor	$18.37 +0.9%	11/8/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$40.00 -> $34.00	Low	View details for Guggenheim rating of Xencor (NASDAQ:XNCR) on 11/8/2023
MGNX MacroGenics	$16.23 +5.3%	11/7/2023	Upgraded by	Guggenheim	-	Neutral -> Buy	$12.00	Low	View details for Guggenheim rating of MacroGenics (NASDAQ:MGNX) on 11/7/2023
SVRA Savara	$4.69 -0.2%	11/7/2023	Initiated by	Guggenheim	-	Buy	$7.00	Low	View details for Guggenheim rating of Savara (NASDAQ:SVRA) on 11/7/2023
UTL Unitil	$50.75 +1.2%	11/6/2023	Initiated by	Guggenheim	-	Neutral		Low	View details for Guggenheim rating of Unitil (NYSE:UTL) on 11/6/2023
DTE DTE Energy	$110.11 0.0%	11/3/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$110.00 -> $103.00	Low	View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 11/3/2023
EIX Edison International	$70.81 +0.2%	11/3/2023	Target Raised by	Guggenheim	-	Neutral -> Neutral	$63.00 -> $66.00	Low	View details for Guggenheim rating of Edison International (NYSE:EIX) on 11/3/2023
ETR Entergy	$107.17 -0.3%	11/3/2023	Target Raised by	Guggenheim	-	Buy -> Buy	$99.00 -> $103.00	Low	View details for Guggenheim rating of Entergy (NYSE:ETR) on 11/3/2023
ETSY Etsy	$68.35 +2.9%	11/3/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$80.00 -> $75.00	Low	View details for Guggenheim rating of Etsy (NASDAQ:ETSY) on 11/3/2023
IQV IQVIA	$238.74 +3.2%	11/3/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$253.00 -> $220.00	Low	View details for Guggenheim rating of IQVIA (NYSE:IQV) on 11/3/2023
SBGI Sinclair	$12.42 +0.6%	11/3/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$30.00 -> $20.00	Low	View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 11/3/2023
W Wayfair	$57.75 +5.5%	11/3/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$100.00 -> $65.00	Low	View details for Guggenheim rating of Wayfair (NYSE:W) on 11/3/2023
STEM Stem	$1.70 +4.9%	11/3/2023	Downgraded by	Guggenheim	-	Buy -> Neutral		Low	View details for Guggenheim rating of Stem (NYSE:STEM) on 11/3/2023
GNRC Generac	$136.10 +1.5%	11/3/2023	Upgraded by	Guggenheim	-	Neutral -> Buy	$142.00	Low	View details for Guggenheim rating of Generac (NYSE:GNRC) on 11/3/2023
CFLT Confluent	$28.53 +4.3%	11/3/2023	Upgraded by	Guggenheim	-	Neutral -> Buy	$23.00	Low	View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 11/3/2023
SEDG SolarEdge Technologies	$56.77 +4.1%	11/2/2023	Downgraded by	Guggenheim	-	Buy -> Neutral		Low	View details for Guggenheim rating of SolarEdge Technologies (NASDAQ:SEDG) on 11/2/2023
NRG NRG Energy	$71.49 +1.6%	11/1/2023	Upgraded by	Guggenheim	-	Neutral -> Buy	$50.00	Low	View details for Guggenheim rating of NRG Energy (NYSE:NRG) on 11/1/2023
TRML Tourmaline Bio	$15.09 -2.6%	10/31/2023	Initiated by	Guggenheim	-	Buy	$50.00	Low	View details for Guggenheim rating of Tourmaline Bio (NASDAQ:TRML) on 10/31/2023
DNTH Dianthus Therapeutics	$23.42 +0.8%	10/30/2023	Initiated by	Guggenheim	-	Buy	$45.00	Low	View details for Guggenheim rating of Dianthus Therapeutics (NASDAQ:DNTH) on 10/30/2023
IDA IDACORP	$94.13 -0.2%	10/27/2023	Initiated by	Guggenheim	-	Buy	$104.00	Low	View details for Guggenheim rating of IDACORP (NYSE:IDA) on 10/27/2023
LYV Live Nation Entertainment	$90.08 +1.8%	10/26/2023	Target Raised by	Guggenheim	-	Buy -> Buy	$124.00 -> $125.00	Low	View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 10/26/2023
AKAM Akamai Technologies	$101.76 +0.9%	10/26/2023	Upgraded by	Guggenheim	-	Sell -> Neutral		Low	View details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 10/26/2023
FND Floor & Decor	$110.00 +1.4%	10/23/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$115.00 -> $95.00	Low	View details for Guggenheim rating of Floor & Decor (NYSE:FND) on 10/23/2023
DT Dynatrace	$46.23 +1.5%	10/23/2023	Initiated by	Guggenheim	-	Buy	$58.00	Low	View details for Guggenheim rating of Dynatrace (NYSE:DT) on 10/23/2023
DDOG Datadog	$126.44 +3.6%	10/23/2023	Initiated by	Guggenheim	-	Neutral		Low	View details for Guggenheim rating of Datadog (NASDAQ:DDOG) on 10/23/2023
MCD McDonald's	$276.81 +0.4%	10/19/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$330.00 -> $285.00	Low	View details for Guggenheim rating of McDonald’s (NYSE:MCD) on 10/19/2023
ANIP ANI Pharmaceuticals	$66.14 +0.8%	10/19/2023	Reiterated by	Guggenheim	-	Buy -> Buy	$72.00	Low	View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 10/19/2023
NFLX Netflix	$577.75 +4.2%	10/19/2023	Reiterated by	Guggenheim	-	Buy -> Buy	$460.00	Low	View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/19/2023
TSLA Tesla	$144.68 +1.9%	10/19/2023	Reiterated by	Guggenheim	-	Sell -> Sell	$125.00	Low	View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 10/19/2023
NOW ServiceNow	$740.95 +2.6%	10/19/2023	Reiterated by	Guggenheim	-	Buy -> Buy	$657.00	Low	View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 10/19/2023
ROIV Roivant Sciences	$10.94 +3.2%	10/17/2023	Initiated by	Guggenheim	-	Buy	$17.00	Low	View details for Guggenheim rating of Roivant Sciences (NASDAQ:ROIV) on 10/17/2023
ES Eversource Energy	$60.34 +0.1%	10/13/2023	Downgraded by	Guggenheim	-	Buy -> Neutral	$60.00	Low	View details for Guggenheim rating of Eversource Energy (NYSE:ES) on 10/13/2023
EXEL Exelixis	$23.29 +1.8%	10/11/2023	Reiterated by	Guggenheim	-	Buy -> Buy	$30.00	Low	View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 10/11/2023
DIS Walt Disney	$113.72 +1.5%	10/10/2023	Target Lowered by	Guggenheim	-		$125.00 -> $115.00	Low	View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 10/10/2023
NMRA Neumora Therapeutics	$10.30 -1.1%	10/10/2023	Initiated by	Guggenheim	-	Buy	$22.00	Low	View details for Guggenheim rating of Neumora Therapeutics (NASDAQ:NMRA) on 10/10/2023
Exposed: 10 CENT Crypto to Explode April 20th? (Ad) Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024
WEC WEC Energy Group	$81.97	10/9/2023	Target Lowered by	Guggenheim	-		$94.00 -> $84.00	Low	View details for Guggenheim rating of WEC Energy Group (NYSE:WEC) on 10/9/2023
SRE Sempra	$71.53 +0.6%	10/9/2023	Target Lowered by	Guggenheim	-		$86.00 -> $76.00	Low	View details for Guggenheim rating of Sempra (NYSE:SRE) on 10/9/2023
SR Spire	$61.17 -0.3%	10/9/2023	Target Lowered by	Guggenheim	-		$65.00 -> $55.00	Low	View details for Guggenheim rating of Spire (NYSE:SR) on 10/9/2023
SO Southern	$73.26 +0.4%	10/9/2023	Target Lowered by	Guggenheim	-		$80.00 -> $72.00	Low	View details for Guggenheim rating of Southern (NYSE:SO) on 10/9/2023
PPL PPL	$27.24 -0.5%	10/9/2023	Target Lowered by	Guggenheim	-		$31.00 -> $27.00	Low	View details for Guggenheim rating of PPL (NYSE:PPL) on 10/9/2023
POR Portland General Electric	$43.54 +0.6%	10/9/2023	Target Lowered by	Guggenheim	-		$48.00 -> $45.00	Low	View details for Guggenheim rating of Portland General Electric (NYSE:POR) on 10/9/2023
PNW Pinnacle West Capital	$74.50 -0.3%	10/9/2023	Target Lowered by	Guggenheim	-		$83.00 -> $73.00	Low	View details for Guggenheim rating of Pinnacle West Capital (NYSE:PNW) on 10/9/2023
PEG Public Service Enterprise Group	$66.49 -0.3%	10/9/2023	Target Lowered by	Guggenheim	-		$70.00 -> $64.00	Low	View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 10/9/2023
PCG PG&E	$16.96 +0.1%	10/9/2023	Target Lowered by	Guggenheim	-		$21.00 -> $19.00	Low	View details for Guggenheim rating of PG&E (NYSE:PCG) on 10/9/2023
OGS ONE Gas	$64.52 -0.2%	10/9/2023	Target Lowered by	Guggenheim	-		$73.00 -> $64.00	Low	View details for Guggenheim rating of ONE Gas (NYSE:OGS) on 10/9/2023
OGE OGE Energy	$33.93 -0.4%	10/9/2023	Target Lowered by	Guggenheim	-		$36.00 -> $32.00	Low	View details for Guggenheim rating of OGE Energy (NYSE:OGE) on 10/9/2023
NWN Northwest Natural	$38.30 +0.8%	10/9/2023	Target Lowered by	Guggenheim	-		$42.00 -> $37.00	Low	View details for Guggenheim rating of Northwest Natural (NYSE:NWN) on 10/9/2023
NWE NorthWestern Energy Group	$50.45 +0.1%	10/9/2023	Target Lowered by	Guggenheim	-		$48.00 -> $41.00	Low	View details for Guggenheim rating of NorthWestern Energy Group (NYSE:NWE) on 10/9/2023
NJR New Jersey Resources	$43.44 -0.2%	10/9/2023	Target Lowered by	Guggenheim	-		$47.00 -> $42.00	Low	View details for Guggenheim rating of New Jersey Resources (NYSE:NJR) on 10/9/2023
NI NiSource	$27.93 +0.1%	10/9/2023	Target Lowered by	Guggenheim	-		$30.00 -> $27.00	Low	View details for Guggenheim rating of NiSource (NYSE:NI) on 10/9/2023
NEE NextEra Energy	$66.18 +1.3%	10/9/2023	Target Lowered by	Guggenheim	-		$73.00 -> $65.00	Low	View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 10/9/2023
LNT Alliant Energy	$49.97 +0.2%	10/9/2023	Target Lowered by	Guggenheim	-		$49.00 -> $43.00	Low	View details for Guggenheim rating of Alliant Energy (NASDAQ:LNT) on 10/9/2023
FE FirstEnergy	$38.12 -0.2%	10/9/2023	Target Lowered by	Guggenheim	-		$44.00 -> $38.00	Low	View details for Guggenheim rating of FirstEnergy (NYSE:FE) on 10/9/2023
EXC Exelon	$37.56 -0.3%	10/9/2023	Target Lowered by	Guggenheim	-		$45.00 -> $41.00	Low	View details for Guggenheim rating of Exelon (NASDAQ:EXC) on 10/9/2023
EVRG Evergy	$52.25 0.0%	10/9/2023	Target Lowered by	Guggenheim	-		$62.00 -> $54.00	Low	View details for Guggenheim rating of Evergy (NYSE:EVRG) on 10/9/2023
ETR Entergy	$107.17 -0.3%	10/9/2023	Target Lowered by	Guggenheim	-		$113.00 -> $99.00	Low	View details for Guggenheim rating of Entergy (NYSE:ETR) on 10/9/2023
ES Eversource Energy	$60.34 +0.1%	10/9/2023	Target Lowered by	Guggenheim	-		$80.00 -> $70.00	Low	View details for Guggenheim rating of Eversource Energy (NYSE:ES) on 10/9/2023
EIX Edison International	$70.81 +0.2%	10/9/2023	Target Lowered by	Guggenheim	-		$74.00 -> $63.00	Low	View details for Guggenheim rating of Edison International (NYSE:EIX) on 10/9/2023
ED Consolidated Edison	$92.83 +0.1%	10/9/2023	Target Lowered by	Guggenheim	-		$85.00 -> $82.00	Low	View details for Guggenheim rating of Consolidated Edison (NYSE:ED) on 10/9/2023
DUK Duke Energy	$98.20 +0.1%	10/9/2023	Target Lowered by	Guggenheim	-		$102.00 -> $93.00	Low	View details for Guggenheim rating of Duke Energy (NYSE:DUK) on 10/9/2023
DTE DTE Energy	$110.11 0.0%	10/9/2023	Target Lowered by	Guggenheim	-		$124.00 -> $110.00	Low	View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 10/9/2023
D Dominion Energy	$50.67 +0.1%	10/9/2023	Target Lowered by	Guggenheim	-		$56.00 -> $49.00	Low	View details for Guggenheim rating of Dominion Energy (NYSE:D) on 10/9/2023
CPK Chesapeake Utilities	$105.67 0.0%	10/9/2023	Target Lowered by	Guggenheim	-		$112.00 -> $99.00	Low	View details for Guggenheim rating of Chesapeake Utilities (NYSE:CPK) on 10/9/2023
CNP CenterPoint Energy	$28.73 -0.2%	10/9/2023	Target Lowered by	Guggenheim	-		$34.00 -> $29.00	Low	View details for Guggenheim rating of CenterPoint Energy (NYSE:CNP) on 10/9/2023
CMS CMS Energy	$59.90 -0.2%	10/9/2023	Target Lowered by	Guggenheim	-		$61.00 -> $54.00	Low	View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 10/9/2023
AWK American Water Works	$119.86 +0.5%	10/9/2023	Target Lowered by	Guggenheim	-		$147.00 -> $126.00	Low	View details for Guggenheim rating of American Water Works (NYSE:AWK) on 10/9/2023
AVA Avista	$35.56 +0.6%	10/9/2023	Target Lowered by	Guggenheim	-		$33.00 -> $26.00	Low	View details for Guggenheim rating of Avista (NYSE:AVA) on 10/9/2023
ALE ALLETE	$59.80 -0.3%	10/9/2023	Target Lowered by	Guggenheim	-		$49.00 -> $41.00	Low	View details for Guggenheim rating of ALLETE (NYSE:ALE) on 10/9/2023
AEP American Electric Power	$85.56 +0.8%	10/9/2023	Target Lowered by	Guggenheim	-		$96.00 -> $85.00	Low	View details for Guggenheim rating of American Electric Power (NASDAQ:AEP) on 10/9/2023
AEE Ameren	$74.02 -0.5%	10/9/2023	Target Lowered by	Guggenheim	-		$85.00 -> $75.00	Low	View details for Guggenheim rating of Ameren (NYSE:AEE) on 10/9/2023
ARM ARM	96.04 +3.1%	10/9/2023	Initiated by	Guggenheim	-	Buy	64.00	Low	View details for Guggenheim rating of ARM (NASDAQ:ARM) on 10/9/2023
WBD Warner Bros. Discovery	$8.44 -0.4%	10/4/2023	Target Lowered by	Guggenheim	-		$18.00 -> $15.00	Low	View details for Guggenheim rating of Warner Bros. Discovery (NASDAQ:WBD) on 10/4/2023
DKNG DraftKings	$41.21 +1.6%	10/4/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$38.00 -> $37.00	Low	View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 10/4/2023
SNDX Syndax Pharmaceuticals	$20.97 +0.0%	10/3/2023	Target Raised by	Guggenheim	-		$42.00 -> $43.00	Low	View details for Guggenheim rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 10/3/2023
EVRG Evergy	$52.25 0.0%	10/3/2023	Target Lowered by	Guggenheim	-		$68.00 -> $62.00	Low	View details for Guggenheim rating of Evergy (NYSE:EVRG) on 10/3/2023
PARA Paramount Global	$12.74 +2.9%	10/2/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$21.00 -> $19.00	Low	View details for Guggenheim rating of Paramount Global (NASDAQ:PARA) on 10/2/2023
GPCR Structure Therapeutics	$36.09 +0.2%	10/2/2023	Target Raised by	Guggenheim	-		$50.00 -> $92.00	Low	View details for Guggenheim rating of Structure Therapeutics (NASDAQ:GPCR) on 10/2/2023
META Meta Platforms	$496.10 +3.0%	9/27/2023	Target Raised by	Guggenheim	-	Buy -> Buy	$375.00 -> $380.00	Low	View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 9/27/2023
NOVA Sunnova Energy International	$3.93 +2.6%	9/27/2023	Target Lowered by	Guggenheim	-		$30.00 -> $17.00	Low	View details for Guggenheim rating of Sunnova Energy International (NYSE:NOVA) on 9/27/2023
IMVT Immunovant	$28.61 -0.5%	9/27/2023	Target Raised by	Guggenheim	-		$32.00 -> $48.00	Low	View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 9/27/2023
EXEL Exelixis	$23.29 +1.8%	9/25/2023	Target Raised by	Guggenheim	-	Buy -> Buy	$27.00 -> $30.00	Low	View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 9/25/2023
MSFT Microsoft	$407.57 +1.6%	9/25/2023	Upgraded by	Guggenheim	-	Sell -> Neutral		Low	View details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 9/25/2023
IMVT Immunovant	$28.61 -0.5%	9/22/2023	Reiterated by	Guggenheim	-	Buy -> Buy	$32.00	Low	View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 9/22/2023
MCW Mister Car Wash	$7.03 +2.8%	9/22/2023	Reiterated by	Guggenheim	-	Buy -> Buy	$11.00	Low	View details for Guggenheim rating of Mister Car Wash (NYSE:MCW) on 9/22/2023
NKE NIKE	$94.04 -0.2%	9/22/2023	Reiterated by	Guggenheim	-	Buy -> Buy	$135.00	Low	View details for Guggenheim rating of NIKE (NYSE:NKE) on 9/22/2023
ORCL Oracle	$115.07 +0.5%	9/22/2023	Reiterated by	Guggenheim	-	Buy -> Buy	$150.00	Low	View details for Guggenheim rating of Oracle (NYSE:ORCL) on 9/22/2023
TVTX Travere Therapeutics	$5.74 -1.9%	9/22/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$25.00 -> $18.00	Low	View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 9/22/2023
CRL Charles River Laboratories International	$239.98 +3.2%	9/22/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$255.00 -> $225.00	Low	View details for Guggenheim rating of Charles River Laboratories International (NYSE:CRL) on 9/22/2023
RUN Sunrun	$10.27 +2.2%	9/21/2023	Target Raised by	Guggenheim	-	Buy -> Buy	$35.00 -> $36.00	Low	View details for Guggenheim rating of Sunrun (NASDAQ:RUN) on 9/21/2023
TKO TKO Group	$95.67 +0.2%	9/21/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$130.00 -> $126.00	Low	View details for Guggenheim rating of TKO Group (NYSE:TKO) on 9/21/2023
TSLA Tesla	$144.68 +1.9%	9/18/2023	Reiterated by	Guggenheim	-	Sell -> Sell	$125.00	Low	View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 9/18/2023
PLNT Planet Fitness	$60.45 +1.8%	9/18/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$80.00 -> $70.00	Low	View details for Guggenheim rating of Planet Fitness (NYSE:PLNT) on 9/18/2023
RL Ralph Lauren	$168.03 +3.7%	9/18/2023	Upgraded by	Guggenheim	-	Neutral -> Buy	$166.00	Low	View details for Guggenheim rating of Ralph Lauren (NYSE:RL) on 9/18/2023
XPOF Xponential Fitness	$12.59 -0.9%	9/15/2023	Target Lowered by	Guggenheim	-	Buy -> Buy	$32.00 -> $30.00	Low	View details for Guggenheim rating of Xponential Fitness (NYSE:XPOF) on 9/15/2023
ANIP ANI Pharmaceuticals	$66.14 +0.8%	9/13/2023	Reiterated by	Guggenheim	-	Buy -> Buy	$72.00	Low	View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 9/13/2023

MarketBeat Community Rating for Guggenheim

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		24,037 (Vote Outperform)
Underperform Votes:		20,773 (Vote Underperform)
Total Votes:		44,810

MarketBeat's community ratings are surveys of what our community members think about Guggenheim and other research firms. Vote "Outperform" if you believe Guggenheim's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Guggenheim's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Guggenheim Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Guggenheim

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info